US 9353176
Method of treating osteoarthritis with an antibody to NGF
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 9353176 (Method of treating osteoarthritis with an antibody to NGF) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/3955, A61K45/06